Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl D Regillo

Showing results (71-80 of 146) with videos related to

Pageof 15
Sort By:
Ophthalmology|January 5, 2024
Risk of Endophthalmitis Based on Cumulative Number of Anti-VEGF Intravitreal InjectionsRachel N Israilevich, Hana Mansour, Samir N Patel, et al.
American Journal of Ophthalmology|October 24, 2006
Endophthalmitis after open globe injury: microbiologic spectrum and susceptibilities of isolatesSachin Chhabra, Derek Y Kunimoto, Lubna Kazi, et al.
Retina (Philadelphia, Pa.)|February 27, 2015
PROSPECTIVE EVALUATION OF VISUAL ACUITY AGREEMENT BETWEEN STANDARD EARLY TREATMENT DIABETIC RETINOPATHY STUDY CHART AND A HANDHELD EQUIVALENT IN EYES WITH RETINAL PATHOLOGYEhsan Rahimy, Sahitya Reddy, Francis Char DeCroos, et al.
Ophthalmology|July 13, 2014
Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degenerationAllen C Ho, Brandon G Busbee, Carl D Regillo, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 21, 2021
Full-thickness macular holes after surgical repair of primary rhegmatogenous retinal detachments: incidence, clinical characteristics, and outcomesMatthew R Starr, Crystal Lee, Diego Arias, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|October 12, 2011
Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical responseRichard S Kaiser, Omesh P Gupta, Carl D Regillo, et al.
Retina (Philadelphia, Pa.)|November 28, 2007
Intravitreal bevacizumab (avastin) in central retinal vein occlusionJason Hsu, Richard S Kaiser, Arunan Sivalingam, et al.
Investigative Ophthalmology & Visual Science|November 26, 2009
Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26Dexter Hadley, Anton Orlin, Gary Brown, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 19, 2017
Use of Corticosteroids in the Treatment of Patients With Diabetic Macular Edema Who Have a Suboptimal Response to Anti-VEGF: Recommendations of an Expert PanelCarl D Regillo, David G Callanan, Diana V Do, et al.
American Journal of Ophthalmology|July 9, 2018
Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor InjectionsDurga S Borkar, Anthony Obeid, Daniel C Su, et al.
Pageof 15

Showing results (71-80 of 146) with videos related to

Sort By:
Pageof 15
Ophthalmology|January 5, 2024
Risk of Endophthalmitis Based on Cumulative Number of Anti-VEGF Intravitreal InjectionsRachel N Israilevich, Hana Mansour, Samir N Patel, et al.
American Journal of Ophthalmology|October 24, 2006
Endophthalmitis after open globe injury: microbiologic spectrum and susceptibilities of isolatesSachin Chhabra, Derek Y Kunimoto, Lubna Kazi, et al.
Retina (Philadelphia, Pa.)|February 27, 2015
PROSPECTIVE EVALUATION OF VISUAL ACUITY AGREEMENT BETWEEN STANDARD EARLY TREATMENT DIABETIC RETINOPATHY STUDY CHART AND A HANDHELD EQUIVALENT IN EYES WITH RETINAL PATHOLOGYEhsan Rahimy, Sahitya Reddy, Francis Char DeCroos, et al.
Ophthalmology|July 13, 2014
Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degenerationAllen C Ho, Brandon G Busbee, Carl D Regillo, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 21, 2021
Full-thickness macular holes after surgical repair of primary rhegmatogenous retinal detachments: incidence, clinical characteristics, and outcomesMatthew R Starr, Crystal Lee, Diego Arias, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|October 12, 2011
Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical responseRichard S Kaiser, Omesh P Gupta, Carl D Regillo, et al.
Retina (Philadelphia, Pa.)|November 28, 2007
Intravitreal bevacizumab (avastin) in central retinal vein occlusionJason Hsu, Richard S Kaiser, Arunan Sivalingam, et al.
Investigative Ophthalmology & Visual Science|November 26, 2009
Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26Dexter Hadley, Anton Orlin, Gary Brown, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 19, 2017
Use of Corticosteroids in the Treatment of Patients With Diabetic Macular Edema Who Have a Suboptimal Response to Anti-VEGF: Recommendations of an Expert PanelCarl D Regillo, David G Callanan, Diana V Do, et al.
American Journal of Ophthalmology|July 9, 2018
Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor InjectionsDurga S Borkar, Anthony Obeid, Daniel C Su, et al.
Pageof 15